Patent · US Expired

Controlled release formulation

US6673369B2 · kind B2 · utility

28Cited by
13References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2002
Grant dateJan 6, 2004
Priority date
Expiry dateJan 26, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2054
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a controlled release pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w, of one or more of rate controlling cellulosic ether polymers.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.